-
Forward Look
Putting the Immune System in OverdriveQ&A with medical oncologist and immunotherapy researcher Patrick Ott.
by Chris Palmer
-
Forward Look
A Blood Test for CancerLiquid biopsies are a leading edge of cancer research.
by Stephen Ornes
-
Forward Look
Melanoma Risk Increased in Some Lymphoma SurvivorsStudy pinpoints group that may benefit from close surveillance.
by Sharon Reynolds
-
Forward Look
Aspirin Recommended to Reduce Colorectal Cancer RiskTask force formally recognizes the benefits, with caveats.
by Yasmine Iqbal
-
Forward Look
Fine-Tuning Treatments for Triple-Negative Breast CancerStudies aim to identify best available treatments and find new ones.
by Cameron Walker
-
The Power of 1Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
-
Healthy Habits
What’s The Beef?Get the facts about meat consumption and cancer risk.
by Brenda Conaway
-
From the Editor-in-Chief
Early-Stage Prostate Cancer: To Treat or Not To TreatStrategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
-
Forward Look
Should the Age to Buy Cigarettes Be 21?Q&A with CDC's Brian King on reducing teen access to tobacco products.
by Chris Palmer
-
Forward Look
Reducing Re-excisionNew guidelines and techniques aim to limit additional breast cancer surgeries.
by Kendall K. Morgan
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
